PHARMA RESEARCH BIO Co., Ltd. (XKON:A217950) announced a private placement of 3rd unregistered coupon unguaranteed private convertible bonds for gross proceeds of KRW 1,500,000,000 on July 20, 2017. The transaction includes participations from ARK Impact Multi-Strategy Hedge Fund 1 for KRW 1,500,000,000. This transaction has been approved by board of directors on July 20, 2017. The issuance of bonds pursuant to the transaction is zero-coupon. The yield to maturity is 6%. The bonds will mature on July 20, 2023. The conversion rate is 100% and conversion price is KRW 20,850. Number of shares pursuant to the conversion is 71,942. The conversion period is from July 21, 2018 to June 20, 2023. The subscription date is July 20, 2017. The payment date is July 20, 2017.